Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
01 2Sanofi
02 4Dr. Reddy's Laboratories
03 4Alfred E Tiefenbacher GmbH
04 2medac
05 2AOP Health
06 6Accord healthcare
07 2Actavis Inc
08 2Alembic Pharmaceuticals Limited
09 8Alphapharm PTY Ltd
10 4Apotex Inc
11 2Aristo Pharma GmbH
12 8Arrotex Pharmaceuticals
13 2Aurobindo Pharma Limited
14 2Aurovitas Spain, Sau
15 4Bluefish Pharmaceuticals AB
16 4Cipla
17 2Cipla Medpro South Africa
18 2Deva Holding AS
19 2Devatis AG
20 18GSK
21 2Gilead Sciences
22 2Indoco Remedies Limited
23 2Kern Pharma S.L.
24 2Mepha Pharma
25 2OrPha Swiss
26 2PH HEALTH
27 2Reig Jofre
28 6Sandoz B2B
29 16Seekwell
30 2Sigmapharm Laboratories, LLC
31 2Sun Pharmaceutical Industries Limited
32 4Teva Pharmaceutical Industries
33 6Viatris
34 2Vivanta Generics Sro
35 2Zentiva
36 2Zydus Pharmaceuticals
01 1Ambrisentan 10Mg 30 Joined' Oral Use
02 1Ambrisentan 5Mg 30 Joined' Oral Use
03 2Antic-calc Tablet, Film Coated
04 4FCT
05 50Film Coated Tablet
06 2Film Coated Tablet - Oral
07 2Film-Coated Tablet For Oral Use,
08 10Film-Coated Tablets
09 6TABLET
10 20TABLET;ORAL
11 8Tablet
12 32tablet
01 10Allowed
02 11Approved
03 17Authorized
04 6Cancelled
05 2DISCN
06 2Deregistered
07 6Generic
08 2Originator
09 6Prescription
10 18RX
11 4Status- Under Registration
12 2Suspensed
13 52Blank
01 18AMBRISENTAN
02 2AMBRISENTAN ACCORD
03 2AMBRISENTAN DR. REDDY'S
04 2AMBRISENTAN MEDAC
05 2AMBRISENTAN MYLAN
06 2AMBRISENTAN TEVA
07 2AMBRISENTAN ZENTIVA ITALY
08 2APO-AMBRISENTAN
09 2Ambient Aristo
10 4Ambrisentan Accord
11 2Ambrisentan Alembic
12 2Ambrisentan Aop
13 2Ambrisentan Aurovitas
14 4Ambrisentan Bluefish
15 2Ambrisentan Cipla
16 2Ambrisentan Devatis
17 2Ambrisentan Kern Pharma
18 2Ambrisentan Orpha
19 2Ambrisentan Sala
20 4Ambrisentan Sandoz
21 2Ambrisentan Teva
22 10Ambrisentan Viatris
23 2Ambrisentan Vivanta
24 2Ambrisentan Zentiva
25 2Ambrisentan-Mepha
26 8Cipla Ambrisentan
27 2LETAIRIS
28 8PULMORIS
29 2SANDOZ AMBRISENTAN TABLETS
30 4VOLIBRIS
31 20Volibris
32 1Volibris 10 mg
33 1Volibris 5 mg
34 1Volmaro 10
35 1Volmaro 5
36 10Blank
01 32Australia
02 6Canada
03 4Germany
04 4India
05 16Italy
06 2Norway
07 4South Africa
08 25Spain
09 13Sweden
10 10Switzerland
11 2Turkey
12 20USA
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Ambrisentan Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 5mg
Packaging :
Approval Date : 10/05/2021
Application Number : 67734
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN MEDAC
Dosage Form : Film-Coated Tablets
Dosage Strength : 10 mg
Packaging : 30 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Sanofi is a pioneer in Diabetes Solutions, Human Vaccines, Innovative Drugs, Consumer Healthcare, and the new Genzyme.
Regulatory Info : Allowed
Registration Country : Switzerland
Brand Name : Ambrisentan Zentiva
Dosage Form : Film Coated Tablet
Dosage Strength : 10mg
Packaging :
Approval Date : 10/05/2021
Application Number : 67734
Regulatory Info : Allowed
Registration Country : Switzerland
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : India
Brand Name :
Dosage Form : Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info :
Registration Country : India
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN DR. REDDY'S
Dosage Form : Film-Coated Tablets
Dosage Strength : 10 mg
Packaging : 30 UNITS 10 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN DR. REDDY'S
Dosage Form : Film-Coated Tablets
Dosage Strength : 5 mg
Packaging : 30 UNITS 5 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 5MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
We are the TIEFENBACHER GROUP, Health Pioneers since 1963.
Regulatory Info : Status- Under Registration
Registration Country : Germany
Brand Name :
Dosage Form : Film Coated Tablet
Dosage Strength : 10MG
Packaging :
Approval Date :
Application Number :
Regulatory Info : Status- Under Registration
Registration Country : Germany
medac CDMO: Tailored CDMO services for injectables in syringes, cartridges & vials – aseptic, reliable, flexible and a solution ahead.
Regulatory Info :
Registration Country : Italy
Brand Name : AMBRISENTAN MEDAC
Dosage Form : Film-Coated Tablets
Dosage Strength : 5 mg
Packaging : 30 UNITS 5 MG - ORAL USE
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Italy
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208252
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LETAIRIS
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2007-06-15
Application Number : 22081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : LETAIRIS
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2007-06-15
Application Number : 22081
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-04-10
Application Number : 208354
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-04-10
Application Number : 208354
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 5MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208441
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : AMBRISENTAN
Dosage Form : TABLET;ORAL
Dosage Strength : 10MG
Packaging :
Approval Date : 2019-03-28
Application Number : 208441
Regulatory Info : RX
Registration Country : USA
